M2-like TAMs induced resistance to chemotherapy in primary osteosarcoma cells, by releasing IL-1β, which in response caused the overexpression of IL-34, vasculogenesis, and osteosarcoma growth [39]. The gene discussed is IL34; the disease is osteosarcoma.